Fig. 5From: Efficacy and potential use of novel sustained release fillers as intracanal medicaments against Enterococcus faecalis biofilm in vitroPercentage of mature biofilm viability after exposure to SRF-CPC and SRF-Placebo at increasing time periods. Data expressed as mean with standard deviation. *P < 0.05, compared with SRF-Placebo and control sample; n = 4Back to article page